You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恆指跌幅擴至近500點失守26,700 兩大醫藥及手機股挫逾4%-7%
阿思達克 01-30 10:52
美股昨晚先升後回,聯儲局如期維持利率不變,但聲明指消費支出放緩至僅溫和,主席鮑威爾更指中國「武肺」疫情對經濟前景構成不確定性,美企季績參差,加上美國12月NAR季調後成屋銷售環比意外急降4.9%,道指及納指僅續微,標普反覆微吐0.1%。 內地新型冠狀病毒感染肺炎確診個案突破7,700宗,死亡人數增至170人。亞太區股市今早普遍受壓,尤其是台灣加權指數鼠年首個交易日復市追瀉592點或4.9%,報11,526。 港股承鼠年首個交易日追挫789點或2.8%頹勢,今早低開130點失守百天線後,跌幅持續擴大至491或1.8%,報26,669,為去年12月11日以來最低,成交額394億元。 藍籌股除太古A(00019.HK)逆市微彈外,無一倖免。瑞信指「武肺」疫情將影響內地智能手機生產及銷售,瑞聲(02018.HK)及舜宇(02382.HK)低見55.3元及128.6元,現造55.45元及129.2元,續挫7.4%及6.7%,後者失守50天線(135.4元)。此外,重磅股騰訊(00700.HK)及中移動(00941.HK)跌1.3%及3.8%,分別報378.4及65元,後者失守10天及20天線。 石藥(01093.HK)及中生製藥(01177.HK)連跌第四天,股價均失守百天線(17.98元及10.97元),低見17.68元及10.6元,分別報17.72元及10.64元,續挫4.1%及4.5%。 內地肺炎疫情肆虐,銀娛(00027.HK)、金沙(01928.HK)及蒙牛(02319.HK)續跌2.4%-2.9%,分別報51.9元/37.85元/30.25元,前兩者股價跌破牛熊線。 金融股以友邦(01299.HK)、中國平安(02318.HK)、中銀(02388.HK)及國壽(02628.HK)沽壓較大,股價依次續跌1.5%-2.8%,分別報79.6元/90.25元/19.3元,後者創逾三個月低。(sz/t)~ 阿思達克財經新聞 網址: www.aastocks.com
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account